This inventor holds 2 USPTO granted patents. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Christopher W. Cluff: Innovator in Immunogenic Compositions
Introduction
Christopher W. Cluff is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of immunogenic compositions, holding a total of 2 patents. His work focuses on developing innovative methods and compositions that enhance immunogenic responses.
Latest Patents
Christopher's latest patents include groundbreaking inventions related to immunogenic compositions. One of his notable patents describes compositions and methods for producing immunogenic compositions that comprise a protein antigen cross-linked to an oxoadenine adjuvant. This invention aims to improve the efficacy of vaccines and therapeutic applications.
Career Highlights
Christopher W. Cluff is currently associated with GlaxoSmithKline Biologicals SA, where he continues to advance research in immunology. His expertise and innovative approach have positioned him as a key figure in the development of new immunogenic strategies.
Collaborations
Throughout his career, Christopher has collaborated with esteemed colleagues, including Daniel Larocque and Michael Cochran. These collaborations have fostered a dynamic research environment, leading to the advancement of immunogenic technologies.
Conclusion
Christopher W. Cluff's contributions to the field of immunogenic compositions highlight his role as an influential inventor. His innovative patents and collaborations continue to shape the future of immunology and vaccine development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile